---
schema_version: "secwatch.filing_event.v1"
accession: "0001367644-26-000051"
form_type: "8-K"
ticker: "EBS"
cik: "0001367644"
company_name: "Emergent BioSolutions Inc."
filed_at: "2026-04-30T23:59:59+00:00"
generated_at: "2026-05-15T00:36:25.977101+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Shareholders approve increase in Emergent BioSolutions' stock incentive plan by 5M shares

## Summary
- Shareholders approved amendment to stock incentive plan adding 5M shares, total reserve now 36,208,561 shares.
- Director nominees elected: Dayal, Fowler, Harsanyi, Papa; each received >93% of votes cast (excluding broker non-votes).
- Advisory say-on-pay approved with 58.4% support; 18.2M for, 12.0M against, 0.9M abstain.
- Ratification of Ernst & Young as auditor approved with 96.7% of votes cast.
- Plan amendment changes full-value award counting ratio to 1.0 from 1.6 per share for grants after April 29, 2026.

## SEC filing metadata
- accession: 0001367644-26-000051
- form_type: 8-K
- ticker: EBS
- cik: 0001367644
- company_name: Emergent BioSolutions Inc.
- filed_at: 2026-04-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1367644/000136764426000051/0001367644-26-000051-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1367644/000136764426000051/ebs-20260429.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001367644-26-000051
- JSON: https://secwatch.observer/filing/0001367644-26-000051.json
- Plain text: https://secwatch.observer/filing/0001367644-26-000051.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.